Rivera-Caravaca, José Miguel
Roldán, Vanessa
Martínez-Montesinos, Lorena
Vicente, Vicente
Lip, Gregory Y.H.
Marín, Francisco
Funding for this research was provided by:
Instituto de Salud Carlos III (PI17/01375)
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CB16/11/00385)
Article History
Received: 17 January 2022
Accepted: 31 March 2022
First Online: 11 April 2022
Declarations
:
: GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim and Daiichi-Sankyo. No fees are received personally.There is nothing to disclose for other authors.